This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodison, S. Articles by Tarin, D. Search for Related Content PubMed PubMed Citation Articles by Goodison, S. Articles by Tarin, D.

Rapid Analysis of Distinctive CD44 RNA Splicing Preferences That Characterize Colonic Tumors¹

Nuffield Department of Pathology and Bacteriology, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom [S. G., K. Y., T. S., A. W., H. G., J. B., D. T.], and R&D New Diagnostics, Oncology LP-N1/TU, Boehringer Mannheim GmbH, Werk Tutzing, Bahnhofstrasse 9-15, D-82372 Tutzing, Germany [M. K.]

In normal tissues, the steady-state level of CD44 mRNA is low, and the variety of alternatively spliced transcripts produced by this complex gene is limited. Conversely, increased and disorderly expression of this gene has been observed in a number of types of cancer. This study analyzed the order in which the CD44 variant exons are spliced together in gastrointestinal tumor cell lines and in 20 colonic carcinomas and matched normal mucosa.

We used a PCR-based assay to analyze specific exon junctions at the boundary of the standard and variant regions of the CD44 gene transcripts. This revealed characteristically different splicing preferences in colonic tumor and normal tissues. The junction of exon 5 to exon 8 appeared to be the most prevalent in normal mucosa, whereas the presence of junctions between exon 5 and either exon 7, 9, or 11 were increased markedly in tumor samples.

These observations demonstrate that the unusual variety of CD44 transcripts in cancer cells results from the fidelity of alternative splicing mechanisms being compromised and are potentially useful as tumor cell markers in diagnostic assays.

¹ This work was supported in part by a research contract between Boehringer Mannheim GmbH and University of Oxford.

² To whom requests for reprints should be addressed.

Received 4/21/97. Accepted 6/16/97.

This article has been cited by other articles:

				V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis Clin. Cancer Res., January 1, 2002; 8(1): 61 - 74. [Abstract] [Full Text] [PDF]

				K. Aogi, K. Kitahara, V. Urquidi, D. Tarin, and S. Goodison Comparison of Telomerase and CD44 Expression as Diagnostic Tumor Markers in Lesions of the Thyroid Clin. Cancer Res., October 1, 1999; 5(10): 2790 - 2797. [Abstract] [Full Text] [PDF]

				S. Goodison, K. Yoshida, M. Churchman, and D. Tarin Multiple Intron Retention Occurs in Tumor Cell CD44 mRNA Processing Am. J. Pathol., October 1, 1998; 153(4): 1221 - 1228. [Abstract] [Full Text] [PDF]